Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
Interventions for Tuberculosis Control and Elimination 2002
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
580. Nolan CM. Failure of therapy <strong>for</strong> tuberculosis in human immunodeficiency virus<br />
infection. Am J Med Sci 1992; 304: 168-73.<br />
581. Peloquin CA, MacPhee AA, Berning SE. Malabsorption of antimycobacterial<br />
medications. (Correspondence). N Engl J Med 1993; 329: 1122-3.<br />
582. Berning SE, Huitt GA, Iseman MD, Peloquin CA. Malabsorption of antituberculosis<br />
medications by a patient with AIDS. N Engl J Med 1992; 327: 1817-8.<br />
583. Patel KB, Belmonte R, Crowe HM. Drug malabsorption <strong>and</strong> resistant tuberculosis<br />
in HIV-infected patients.<br />
336-7.<br />
(Correspondence). N Engl J Med 1995; 332:<br />
584. Choudhri SH, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar DS,<br />
Aoki FY, Long R. Pharmacokinetics of antimycobacterial drugs in patients with<br />
tuberculosis, AIDS, <strong>and</strong> diarrhea. Clin Infect Dis 1997; 25: 104-11.<br />
585. Taylor B, Smith PJ. Does AIDS impair the absorption of anti-tuberculosis agents?<br />
Int J Tuberc Lung Dis 1998; 2: 670-5.<br />
586. Brindle RJ, Nunn PP, Githui W, Allen BW, Gathua S, Waiyaki P. Quantitative<br />
bacillary response to treatment in HIV-associated pulmonary tuberculosis.<br />
Rev Respir Dis 1993; 147: 958-61.<br />
Am<br />
587. Iseman MD. Is st<strong>and</strong>ard chemotherapy adequate in tuberculosis patients infected<br />
with the HIV? Am Rev Respir Dis 1987; 136: 1326.<br />
588. Small PM, Schecter GF, Goodman PC, S<strong>and</strong>e MA, Chaisson RE, Hopewell PC.<br />
Treatment of tuberculosis in patients with advanced human immunodeficiency<br />
virus infection. N Engl J Med 1991; 324: 289-94.<br />
589. Schürmann D, Bergmann F, Jautzke G, Fehrenbach FJ, Mauch H, Ruf B. Acute<br />
<strong>and</strong> long-term efficacy of antituberculous treatment in HIV-seropositive patients<br />
with tuberculosis: a study of 36 cases. J Infect 1993; 26: 45-54.<br />
590. B<strong>and</strong>a H, Kang’ombe C, Harries AD, Nyangulu DS, Whitty CJM, Wirima JJ,<br />
Salaniponi FM, Maher D, Nunn P. Mortality rates <strong>and</strong> recurrent rates of tuberculosis<br />
in patients with smear-negative pulmonary tuberculosis <strong>and</strong> tuberculous<br />
pleural effusion who have completed treatment.<br />
968-74.<br />
Int J Tuberc Lung Dis 2000; 4:<br />
591. Perriëns JH, Colebunders RL, Karahunga C, Willame JC, Jeugmans J, Kaboto<br />
M, Mukadi Y, Puwels P, Ryder RW, Prignot J, Piot P. Increased mortality <strong>and</strong><br />
tuberculosis treatment failure rate among human immunodeficiency virus (HIV)<br />
seropositive compared with HIV seronegative patients with pulmonary tuberculosis<br />
treated with “st<strong>and</strong>ard” chemotherapy in Kinshasa, Zaire.<br />
Dis 1991; 144: 750-5.<br />
Am Rev Respir<br />
592. Githui W, Nunn P, Juma E, Karimi F, Brindle R, Kamunyi R, Gathua S,<br />
Gicheha C, Morris J, Omwega M. Cohort study of HIV-positive <strong>and</strong> HIV-negative<br />
tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle<br />
Lung Dis 1992; 73: 203-9.<br />
208
Change language